### [2008-07-1](/news/2008/07/1/index.md)

#  A jury orders pharmaceutical companies GlaxoSmithKline and Novartis to pay $114 million in compensation to the Government of Alabama for overcharging for Medicaid prescription drugs. 




### Source:

1. [AP via Google News](http://ap.google.com/article/ALeqM5h4PI2MxQ4f_sohI7jaIdXH1EbXWwD91L9TC82)

### Related:

1. [China fines Glaxosmithkline US$490 million for its alleged involvement in a bribery scandal. ](/news/2014/09/19/china-fines-glaxosmithkline-us-490-million-for-its-alleged-involvement-in-a-bribery-scandal.md) _Context: $, Glaxosmithkline_
2. [ An Alabama state judge upholds a fraud verdict against AstraZeneca Pharmaceuticals in a Medicaid drug pricing suit but reduces the value of damages to $160 million. ](/news/2008/06/19/an-alabama-state-judge-upholds-a-fraud-verdict-against-astrazeneca-pharmaceuticals-in-a-medicaid-drug-pricing-suit-but-reduces-the-value-of.md) _Context: $, Medicaid_
3. [U.S. District Court for the District of Columbia Judge Ellen S. Huvelle awards Amir Mirza Hekmati, a U.S. Marine who was imprisoned in Iran as a falsely accused CIA spy, a default judgment of $63 million for his ordeal. ](/news/2017/10/3/u-s-district-court-for-the-district-of-columbia-judge-ellen-s-huvelle-awards-amir-mirza-hekmati-a-u-s-marine-who-was-imprisoned-in-iran.md) _Context: $_
4. [Hurricane Harvey is projected to possibly become the second costliest hurricane in the United States's history, with estimates ranging from US$72 billion to over $125 billion. In comparison, Hurricane Katrina's total damage is estimated to be around $118 to $160 billion. ](/news/2017/09/3/hurricane-harvey-is-projected-to-possibly-become-the-second-costliest-hurricane-in-the-united-states-s-history-with-estimates-ranging-from.md) _Context: $_
5. [The Food and Drug Administration has approved the first treatment that genetically engineers patients' own blood cells to destroy acute lymphoblastic leukemia. The approval makes Novartis the proprietor of the first gene therapy to hit the U.S. market. ](/news/2017/08/30/the-food-and-drug-administration-has-approved-the-first-treatment-that-genetically-engineers-patients-own-blood-cells-to-destroy-acute-lymp.md) _Context: Novartis_
